Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials — Frank A. Holtkamp (2011) | RDL Network
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
Article 2011 en
Authors
FH
Frank A. Holtkamp
DZ
Dick de Zeeuw
PG
P. A. de Graeff
Abstract
1 min read
The SBP and albuminuria response to ARB therapy is variable and discordant. Therapies intervening in the renin-angiotensin-aldosterone system with the aim of improving cardiovascular outcomes may therefore require a dual approach targeting both blood pressure and albuminuria.
Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Hans‐Henrik Parving, Mark E. Cooper, William F. Keane, Shahnaz Shahinfar, Gilbert W. Gleim, Barry M. Brenner, Dick de Zeeuw
Liffert Vogt, Carlos Chiurchiu, Harbajan Chadha‐Boreham, Parisa Danaietash, Jasper Dingemanse, Samy Hadjadj, Henry Krum, Gerjan Navis, Eric Neuhart, Aneliya Parvanova, Piero Ruggenenti, A. J. J. Woittiez, Reuven Zimlichman, Giuseppe Remuzzi, Dick de Zeeuw
Hermann Haller, Gian Carlo Viberti, A Mimran, Giuseppe Remuzzi, Ton J. Rabelink, Eberhard Ritz, Lars Christian Rump, Luís M. Ruilope, Shigehiro Katayama, Sadayoshi Ito, Joseph L. Izzo, Andrzej Januszewicz
Alexander Zarbock, Jean Louis Vincent, Daniel De Backer, Rinaldo Bellomo, Matthieu Legrand, Ashish K. Khanna, Marlies Ostermann, Katarzyna Kotfis, Alberto Di Filippo, Patrick M. Wieruszewski, Marc Léone, Massimo Girardis, Ricardo Ferrer, Yuki Kotani, Peter Pickkers, Gennaro De Pascale, Pierre Tissières, Giovanni Landoni
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.